Press Release

Press Release

  • (2022-05-17) Aimedbio develops antibodies with novel targets based on ‘patient big data’
  • - Nam-gu Her, Aimedbios Head of R&D, gives a speech on Introduction to Aimedbios patient-centric AI novel drug therapeutics development and precision medicine at BIOKOREA 2022

    AimedBio uses patient big data and patient-derived samples to develop novel antibody-based therapeutics with high speed and accuracy


    Link to full news:

Contact Us >>